The global market for Coronary Stents was valued at US$9.9 Billion in 2024 and is projected to reach US$13.6 Billion by 2030, growing at a CAGR of 5.4% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.
The development and evolution of coronary stents have been driven by advancements in medical technology and materials science. Early bare-metal stents provided structural support but were associated with a higher risk of restenosis, or re-narrowing of the artery. The introduction of drug-eluting stents significantly reduced this risk by releasing antiproliferative drugs that inhibit the growth of scar tissue. More recently, bioresorbable stents have been developed to provide temporary support and then dissolve, potentially reducing long-term complications. Innovations in stent design, such as thinner struts and enhanced flexibility, have improved the deliverability and performance of stents, making them safer and more effective. Furthermore, advances in imaging and diagnostic technologies have enhanced the precision of stent placement, improving patient outcomes.
The growth in the coronary stent market is driven by several factors. Firstly, the increasing prevalence of coronary artery disease, driven by factors such as aging populations, unhealthy lifestyles, and rising rates of obesity and diabetes, is boosting the demand for stents. Secondly, advancements in stent technology, including the development of next-generation drug-eluting stents and bioresorbable stents, are driving market growth by offering improved safety and efficacy. Thirdly, the expansion of healthcare infrastructure and access to advanced medical treatments in emerging economies is increasing the adoption of coronary stents. Additionally, the growing awareness among patients and healthcare providers about the benefits of minimally invasive procedures for treating CAD is supporting market expansion. Lastly, supportive government policies, healthcare funding, and reimbursement frameworks are facilitating the adoption of advanced stent technologies, ensuring better patient care and driving market growth.
Global Coronary Stents Market - Key Trends & Drivers Summarized
Coronary stents are small, expandable tubes that are inserted into narrowed or blocked coronary arteries to restore blood flow to the heart. These devices play a crucial role in the treatment of coronary artery disease (CAD), which is a leading cause of morbidity and mortality worldwide. Stents help to keep the arteries open after procedures such as angioplasty, where a balloon is used to widen the artery. There are different types of coronary stents, including bare-metal stents (BMS), drug-eluting stents (DES), and bioresorbable stents. Drug-eluting stents are coated with medication that helps prevent the re-narrowing of the artery, while bioresorbable stents gradually dissolve after providing support to the artery.The development and evolution of coronary stents have been driven by advancements in medical technology and materials science. Early bare-metal stents provided structural support but were associated with a higher risk of restenosis, or re-narrowing of the artery. The introduction of drug-eluting stents significantly reduced this risk by releasing antiproliferative drugs that inhibit the growth of scar tissue. More recently, bioresorbable stents have been developed to provide temporary support and then dissolve, potentially reducing long-term complications. Innovations in stent design, such as thinner struts and enhanced flexibility, have improved the deliverability and performance of stents, making them safer and more effective. Furthermore, advances in imaging and diagnostic technologies have enhanced the precision of stent placement, improving patient outcomes.
The growth in the coronary stent market is driven by several factors. Firstly, the increasing prevalence of coronary artery disease, driven by factors such as aging populations, unhealthy lifestyles, and rising rates of obesity and diabetes, is boosting the demand for stents. Secondly, advancements in stent technology, including the development of next-generation drug-eluting stents and bioresorbable stents, are driving market growth by offering improved safety and efficacy. Thirdly, the expansion of healthcare infrastructure and access to advanced medical treatments in emerging economies is increasing the adoption of coronary stents. Additionally, the growing awareness among patients and healthcare providers about the benefits of minimally invasive procedures for treating CAD is supporting market expansion. Lastly, supportive government policies, healthcare funding, and reimbursement frameworks are facilitating the adoption of advanced stent technologies, ensuring better patient care and driving market growth.
Scope of the Study
The report analyzes the Coronary Stents market, presented in terms of market value (US$ Thousand). The analysis covers the key segments and geographic regions outlined below.Segments:
Type (Drug Eluting Stents, Other Types); End-User (Hospitals, Ambulatory Surgery Centers, Other End-Users).Geographic Regions/Countries:
World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Spain; Russia; Rest of Europe; Asia-Pacific; Australia; India; South Korea; Rest of Asia-Pacific; Latin America; Argentina; Brazil; Mexico; Rest of Latin America; Middle East; Iran; Israel; Saudi Arabia; UAE; Rest of Middle East; Africa.Key Insights:
- Market Growth: Understand the significant growth trajectory of the Drug Eluting Stents segment, which is expected to reach US$9.6 Billion by 2030 with a CAGR of a 5.6%. The Other Types segment is also set to grow at 5.1% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, valued at $2.8 Billion in 2024, and China, forecasted to grow at an impressive 7.2% CAGR to reach $1.1 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of major players such as Abbott Cardiovascular, B. Braun Melsungen AG, Becton, Dickinson and Company, Biosensors International Group Ltd., BIOTRONIK SE & Co. KG and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Coronary Stents Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Coronary Stents Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Coronary Stents Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Some of the 60 major companies featured in this Coronary Stents market report include:
- Abbott Cardiovascular
- B. Braun Melsungen AG
- Becton, Dickinson and Company
- Biosensors International Group Ltd.
- BIOTRONIK SE & Co. KG
- Boston Scientific Corporation
- Cook Medical Inc.
- Elixir Medical Corporation
- Lepu Medical Technology (Beijing) Co., Ltd.
- Medtronic PLC
- Meril Life Sciences Pvt. Ltd.
- Microport Scientific Corporation
- Sahajanand Medical Technologies Ltd.
- Terumo Europe N.V.
- Translumina GmbH
Table of Contents
I. METHODOLOGYMII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERSIII. MARKET ANALYSISSOUTH KOREAREST OF ASIA-PACIFICIV. COMPETITION
1. MARKET OVERVIEW
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
UNITED STATES
CANADA
JAPAN
CHINA
EUROPE
FRANCE
GERMANY
ITALY
UNITED KINGDOM
SPAIN
RUSSIA
REST OF EUROPE
ASIA-PACIFIC
AUSTRALIA
INDIA
LATIN AMERICA
MIDDLE EAST
AFRICA
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Cardiovascular
- B. Braun Melsungen AG
- Becton, Dickinson and Company
- Biosensors International Group Ltd.
- BIOTRONIK SE & Co. KG
- Boston Scientific Corporation
- Cook Medical Inc.
- Elixir Medical Corporation
- Lepu Medical Technology (Beijing) Co., Ltd.
- Medtronic PLC
- Meril Life Sciences Pvt. Ltd.
- Microport Scientific Corporation
- Sahajanand Medical Technologies Ltd.
- Terumo Europe N.V.
- Translumina GmbH
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 342 |
| Published | February 2025 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value ( USD | $ 9.9 Billion |
| Forecasted Market Value ( USD | $ 13.6 Billion |
| Compound Annual Growth Rate | 5.4% |
| Regions Covered | Global |
